Product Images Hailey Fe 1.5/30

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Hailey Fe 1.5/30 NDC 68462-503 by Glenmark Pharmaceuticals Inc., Usa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

blistercard1

blistercard1

This appears to be a part of a medication schedule or chart that is meant to be used for two different start days, Sunday or "day-1". The chart is labeled with days of the week and a numbered week system. There are also directions given to take pills in a specific direction from left to right each week. However, without further context or visible information, it is not possible to determine what kind of medication or treatment this chart is meant to be used for.*

blistercard2

blistercard2

This is a set of instructions for using contraceptive pills with Norethindrone Acetate and Ethiny! Estradiol Iablels, UsP, and Ferrous Fumarate Tablets, USP. The instructions are divided into two parts - one for Sunday starters and the other for Day-1 starters. There are labels for the days of the week, starting from Wednesday to Saturday, and an arrow indicating the direction for taking the pills each week from left to right.*

carton

carton

Hailey Fe 1.5/30 is a combined oral contraceptive in a 28 day regimen. Each blister pack contains 21 light green to green tablets of norethindrone acetate and ethinyl estradiol and 7 brown to dark brown tablets of ferrous fumarate. It is to be taken daily as directed by the physician. The packaging includes patient labeling and the full prescribing information is available in the package insert. Hailey Fe 1.5/30 is manufactured by Glenmark Pharmaceuticals Limited in India and distributed in the US by Glenmark Pharmaceuticals Inc. This product does not protect against sexually transmitted diseases or HIV infection.*

eestructure

eestructure

figure1

figure1

This text appears to be a list of studies that compare the use of combined oral contraceptives (COC) with never using them, and the effect on certain health outcomes. The studies include the NICHD Women's Care Study, the French E3N cohort Study, the shanghai Women's Health Study, The Nurses' Health Study II, the Oxford Family Planning Study, and the Danish Sex Hormone Register Study. There are also numerical data presented, such as effect estimates and the risk ratios (RR) for different health outcomes. Overall, this text seems to relate to research on the impact of COC use on health outcomes.*

glenmarklogo

glenmarklogo

label

label

Hailey® Fe 1.5/30 is a tablet-based oral contraceptive medication manufactured by Glenmark Pharmaceuticals Limited in India for Glenmark Pharmaceuticals Inc., USA. It comes in a green blister package with 21 light green to green tablets containing norethindrone acetate, USP 1.5 mg and ethinyl estradiol, USP 30 mcg, and 7 brown to dark brown tablets containing ferrous fumarate, USP 75 mg. It is intended to prevent pregnancy and is to be taken daily for 28 days as directed by a physician. It does not protect against HIV infection (AIDS) or other sexually transmitted diseases. The package is not child-resistant, and all drugs should be kept out of children's reach. See the package insert for full prescribing information.*

logo

logo

norstructure

norstructure

table2

table2

This text presents a mortality rate table per 100,000 women years, categorized by age, smoking status and oral contraceptive use, with mortality rate values and the number of deaths. However, it lacks clear indicators of the units and specific meaning of the data presented.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.